Saturday, July 18, 2020

PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy | Prostate Cancer and Prostatic Diseases

PI-RADS score v.2 in predicting malignancy in patients undergoing 5α-reductase inhibitor therapy | Prostate Cancer and Prostatic Diseases

No comments:

Post a Comment